1 Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
2 Department of Psychology, Indiana University-Purdue University Indianapolis , Indianapolis, Indiana.
J Palliat Med. 2018 Aug;21(8):1107-1113. doi: 10.1089/jpm.2017.0686. Epub 2018 Jun 15.
Patients with advanced cancer often face distressing decisions about chemotherapy. There are conflicting data on the relationships among perceived prognosis, psychological characteristics, and chemotherapy use, which impair the refinement of decision support interventions.
Clarify the relationships among patient and oncologist estimates of life expectancy for 6 and 12 months, chemotherapy use, and patient psychological characteristics.
Secondary analysis of data from two cross-sectional studies.
SETTING/SUBJECTS: One hundred sixty-six patients with advanced stage cancer recruited from ambulatory cancer clinics.
All data were obtained at study enrollment. Patients completed the Adult Hope Scale, Hospital Anxiety and Depression Scale, and Life Orientation Test-Revised. Patients and their oncologists provided estimates of surviving beyond 6 and 12 months. Chemotherapy use was determined by chart review.
There were no significant associations between life-expectancy estimates and chemotherapy use nor patient anxiety, depression, hope, or optimism and chemotherapy use. Patients' life expectancy estimates for 12 months and oncologists' for 6 months were associated with higher patient anxiety and depression. Finally, both oncologist and patient estimates of life expectancy for 6 and 12 months were associated with increased levels of trait hope.
Advanced cancer patients who provide less optimistic estimates of life expectancy have increased anxiety and depression, but do not use chemotherapy more often. Increased patient trait hope is associated with more favorable oncologist estimates. These findings highlight the need for interventions to support both patients and oncologists as they clarify prognostic expectations and patients cope with the psychological distress of a limited life expectancy.
晚期癌症患者在面临化疗决策时常常感到痛苦。目前有关预后感知、心理特征与化疗使用之间关系的数据相互矛盾,这阻碍了决策支持干预措施的完善。
阐明患者和肿瘤医生对 6 个月和 12 个月预期寿命的估计、化疗使用与患者心理特征之间的关系。
对两项横断面研究数据的二次分析。
地点/受试者:从门诊癌症诊所招募的 166 名晚期癌症患者。
所有数据均在研究入组时获得。患者完成成人希望量表、医院焦虑和抑郁量表以及生活取向测验修订版。患者和他们的肿瘤医生提供了超过 6 个月和 12 个月的生存预期估计。通过病历回顾确定化疗使用情况。
生存期预期估计与化疗使用之间、患者焦虑、抑郁、希望或乐观与化疗使用之间均无显著关联。患者对 12 个月的预期生存期和肿瘤医生对 6 个月的预期生存期与较高的患者焦虑和抑郁相关。最后,肿瘤医生和患者对 6 个月和 12 个月的生存期预期均与特质希望水平的升高有关。
对生存期估计较不乐观的晚期癌症患者会出现更高的焦虑和抑郁,但不会更频繁地使用化疗。患者特质希望的增加与肿瘤医生更有利的预后估计相关。这些发现强调需要干预措施来支持患者和肿瘤医生,以明确预后预期,并帮助患者应对有限生存期的心理困扰。